News from °µÍřTV Langone Health
°µÍřTV Langone Health Expands Access To Anal Cancer Screenings, Helped Along By Federal Guidelines. (Fierce Healthcare)
(8/27) °µÍřTV Langone Health has expanded access to high-resolution anoscopies (HRAs) for anal cancer screening in outpatient settings, following 2024 federal guidelines recommending HRAs for at-risk groups, including men who have sex with men, trans women aged 35 and older, and people with HIV aged 45 and older; Jonathan Baker, physician assistant, Department of Surgery, Division of Colon and Rectal Surgery, said, “There’s a whole cohort of patients who are eligible for this screening, following the guidelines, who would’ve had to go to the OR or an outside practice.”
How 3 Systems Use AI Notes To Help Patients Better Understand Their Care. (Becker's Hospital Review)
(8/27) °µÍřTV Langone Health is conducting a randomized controlled trial to evaluate the use of large language models in simplifying discharge instructions, with drafts produced by AI being reviewed by clinicians before reaching patients, according to Jonah Feldman, MD, assistant professor, Department of Medicine, Division of General Internal Medicine and Innovation, who said, “Large language models could have a really great role in simplifying our communication so that patients can understand.” Paul A. Testa, MD, assistant professor, the Ronald O. Perelman Department of Emergency Medicine, chief medical information officer, said, “Nothing we produce goes directly to the patient, yet I easily foresee a day that that will change,” adding, in the “current times, there’s always a clinician in the middle.”
Back To School Family Resource Event Held In Brooklyn. (WPIX-TV New York)
New York (8/27) The National Health Center Week Annual Back to School Family Resource Event in Brooklyn, hosted by °µÍřTV Langone Health, JPMorganChase, and Health First, transformed the Martin Luther Playground in Sunset Park into a hub of health resources, distributing thousands of book bags filled with school supplies and health information to children and families.
Rising Stars: 100 Healthcare Leaders Under 40. (Becker's Hospital Review)
(8/27) Honored by Becker’s as a rising healthcare leader under 40, Kenny Yu, PharmD, MBA, ACE, senior director, Pharmacy Services, has played a pivotal role in building the 340B program and advocating for medication access, contributing to °µÍřTV Langone Health’s top quality rankings.
Discussing The Critical Role Of Gut Health In Aging. (LIVE With Kelly and Mark)
(8/27) Roshini Rajapaksa, MD, clinical associate professor, Department of Medicine, Division of Gastroenterology and Hepatology, discussed the critical role of gut health in aging and its connection to diseases such as cancer, diabetes, and heart disease, emphasizing the importance of maintaining a balanced gut microbiome through probiotics, prebiotics, and a healthy lifestyle including exercise and stress management.
Legionnaires’ Disease Is In The News: Here’s What To Know, How To Spot Symptoms And How To Stay Safe. (CNBC)
(8/27) A Legionnaires’ disease outbreak in New York City has resulted in six deaths and over 100 infections, with health officials investigating an apartment complex in the Bronx after two cases were reported; Michael S. Phillips, MD, associate professor, Department of Medicine, Division of Infectious Diseases and Immunology, chief, hospital epidemiologist, said, “In the summer, there’s a greater risk of this infection, and there are specific antibiotics and ways of detecting it,” emphasizing the importance of awareness and detection.
DecisionDx-SCC Improves Risk Stratification In High-Risk CSCC. (Targeted Oncology)
(8/27) New studies support the use of the gene expression profile test DecisionDx-SCC for guiding treatment decisions in high-risk cutaneous squamous cell carcinoma (cSCC) patients by providing individualized risk predictions for local recurrence and metastasis, outperforming traditional staging systems and aligning with clinical thresholds for adjuvant radiation therapy and surveillance imaging; Désirée Ratner, MD, clinical professor, the Ronald O. Perelman Department of Dermatology, said, “These new data indicate that DecisionDx-SCC test results provide individualized risk predictions that doctors can use to guide risk-aligned escalation or de-escalation of care in their NCCN high-risk SCC patients.”
UGN-102 Redefines Treatment Standards For Low-Grade, Intermediate-Risk NMIBC. (OncLive)
(8/27) The FDA’s approval of mitomycin intravesical solution (UGN-102) for recurrent, low-grade, intermediate-risk non-muscle-invasive bladder cancer marks a shift towards nonsurgical treatment, with William C. Huang, MD, vice chair, clinical affairs, professor, Departments of Urology and Radiology, chief, urology service, Perlmutter Cancer Center, describing it as “a new tool in our armamentarium for the management of bladder cancer,” noting its potential to prevent surgeries and provide durable benefits.
Treatment Response To Antiseizure Medications Can Take More Than One Year. (Diabetes in Control)
(8/26) Many individuals with newly diagnosed focal epilepsy require over a year and multiple antiseizure medications to achieve seizure freedom, as reported in a study in JAMA Neurology, with 59.6% achieving seizure freedom and 27% doing so with their first ASM; Jacqueline A. French, MD, professor, Department of Neurology, Comprehensive Epilepsy Center, said, “Our findings suggest that those with focal epilepsy should expect a long adjustment period as their health care provider determines the best treatment regimen for them.”
How Often Should You Replace Your Bedding? What Experts Say. (TODAY)
(8/27) Philip M. Tierno, PhD, clinical professor, Department of Pathology, emphasizes the need for regular washing and replacement of bedding to prevent the accumulation of allergens and other particles that can exacerbate allergies and asthma.
Noninvasive Monitoring In Ulcerative Colitis: IUS And More. (Medscape)
(8/27)* Michael Dolinger, MD, assistant professor, Department of Pediatrics, has proposed a threefold noninvasive monitoring strategy for ulcerative colitis, emphasizing the use of intestinal ultrasound, fecal calprotectin, and clinical symptom assessment to improve long-term outcomes by achieving precise disease activity monitoring, saying he thinks the strategy “will lead to better long-term outcomes.”
